149 related articles for article (PubMed ID: 33355186)
1. Is COVID-19-Induced Platelet Activation a Cause of Concern for Patients with Cancer?
Lichtenberger LM; Vijayan KV
Cancer Res; 2021 Mar; 81(5):1209-1211. PubMed ID: 33355186
[TBL] [Abstract][Full Text] [Related]
2. Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Uzun G; Pelzl L; Singh A; Bakchoul T
Front Immunol; 2022; 13():837629. PubMed ID: 35273612
[TBL] [Abstract][Full Text] [Related]
3. Platelets and COVID-19.
Rohlfing AK; Rath D; Geisler T; Gawaz M
Hamostaseologie; 2021 Oct; 41(5):379-385. PubMed ID: 34695854
[TBL] [Abstract][Full Text] [Related]
4. Prothrombotic Phenotype in COVID-19: Focus on Platelets.
Barale C; Melchionda E; Morotti A; Russo I
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948438
[TBL] [Abstract][Full Text] [Related]
5. Search for SARS-CoV-2 RNA in platelets from COVID-19 patients.
Bury L; Camilloni B; Castronari R; Piselli E; Malvestiti M; Borghi M; KuchiBotla H; Falcinelli E; Petito E; Amato F; Paliani U; Vaudo G; Cerotto V; Gori F; Becattini C; De Robertis E; Lazzarini T; Castaldo G; Mencacci A; Gresele P
Platelets; 2021 Feb; 32(2):284-287. PubMed ID: 33349108
[TBL] [Abstract][Full Text] [Related]
6. Thrombocytopathy vs Platelet hyper-reactivity in COVID-19: diverse pathologies, disease outcomes and therapeutic implications.
Tafazoli A; Anil Kumar S; Othman M
Platelets; 2022 Jan; 33(1):48-53. PubMed ID: 34847829
[TBL] [Abstract][Full Text] [Related]
7. Platelets contribute to disease severity in COVID-19.
Barrett TJ; Bilaloglu S; Cornwell M; Burgess HM; Virginio VW; Drenkova K; Ibrahim H; Yuriditsky E; Aphinyanaphongs Y; Lifshitz M; Xia Liang F; Alejo J; Smith G; Pittaluga S; Rapkiewicz AV; Wang J; Iancu-Rubin C; Mohr I; Ruggles K; Stapleford KA; Hochman J; Berger JS
J Thromb Haemost; 2021 Dec; 19(12):3139-3153. PubMed ID: 34538015
[TBL] [Abstract][Full Text] [Related]
8. Platelet gene expression and function in patients with COVID-19.
Manne BK; Denorme F; Middleton EA; Portier I; Rowley JW; Stubben C; Petrey AC; Tolley ND; Guo L; Cody M; Weyrich AS; Yost CC; Rondina MT; Campbell RA
Blood; 2020 Sep; 136(11):1317-1329. PubMed ID: 32573711
[TBL] [Abstract][Full Text] [Related]
9. Platelets and SARS-CoV-2 During COVID-19: Immunity, Thrombosis, and Beyond.
Sciaudone A; Corkrey H; Humphries F; Koupenova M
Circ Res; 2023 May; 132(10):1272-1289. PubMed ID: 37167360
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism.
Shen S; Zhang J; Fang Y; Lu S; Wu J; Zheng X; Deng F
J Hematol Oncol; 2021 Apr; 14(1):72. PubMed ID: 33926500
[TBL] [Abstract][Full Text] [Related]
11. Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019.
Petito E; Falcinelli E; Paliani U; Cesari E; Vaudo G; Sebastiano M; Cerotto V; Guglielmini G; Gori F; Malvestiti M; Becattini C; Paciullo F; De Robertis E; Bury L; Lazzarini T; Gresele P;
J Infect Dis; 2021 Mar; 223(6):933-944. PubMed ID: 33280009
[TBL] [Abstract][Full Text] [Related]
12. Integrated analysis of transcriptomic data reveals the platelet response in COVID-19 disease.
Garma LD; Deng H; Goldschmidt E
Sci Rep; 2022 Apr; 12(1):6851. PubMed ID: 35477940
[TBL] [Abstract][Full Text] [Related]
13. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
14. Alterations in platelets during SARS-CoV-2 infection.
Brambilla M; Canzano P; Becchetti A; Tremoli E; Camera M
Platelets; 2022 Feb; 33(2):192-199. PubMed ID: 34384321
[TBL] [Abstract][Full Text] [Related]
15. CD36 mediates SARS-CoV-2-envelope-protein-induced platelet activation and thrombosis.
Tang Z; Xu Y; Tan Y; Shi H; Jin P; Li Y; Teng J; Liu H; Pan H; Hu Q; Cheng X; Ye J; Su Y; Sun Y; Meng J; Zhou Z; Chi H; Wang X; Liu J; Lu Y; Liu F; Dai J; Yang C; Chen S; Liu T
Nat Commun; 2023 Aug; 14(1):5077. PubMed ID: 37604832
[TBL] [Abstract][Full Text] [Related]
16. The Impact of COVID-19 Disease on Platelets and Coagulation.
Wool GD; Miller JL
Pathobiology; 2021; 88(1):15-27. PubMed ID: 33049751
[TBL] [Abstract][Full Text] [Related]
17. Immature platelets in patients with Covid-19: association with disease severity.
Cohen A; Harari E; Yahud E; Cipok M; Bryk G; Lador NK; Mann T; Mayo A; Lev EI
J Thromb Thrombolysis; 2021 Oct; 52(3):708-714. PubMed ID: 34519015
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
19. Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19.
Zhu A; Real F; Capron C; Rosenberg AR; Silvin A; Dunsmore G; Zhu J; Cottoignies-Callamarte A; Massé JM; Moine P; Bessis S; Godement M; Geri G; Chiche JD; Valdebenito S; Belouzard S; Dubuisson J; Lorin de la Grandmaison G; Chevret S; Ginhoux F; Eugenin EA; Annane D; Bordé EC; Bomsel M
Cell Mol Life Sci; 2022 Jun; 79(7):365. PubMed ID: 35708858
[TBL] [Abstract][Full Text] [Related]
20. Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury.
Rossouw TM; Anderson R; Manga P; Feldman C
Front Immunol; 2022; 13():776861. PubMed ID: 35185878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
